Braeburn Presents New Data at 2026 ASCP Annual Meeting Demonstrating Opioid Withdrawal Suppression at Low Buprenorphine Plasma Concentrations

PLYMOUTH MEETING, Pa., May 28, 2026 /PRNewswire/ -- Braeburn Inc. today announced the presentation of three posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting in Miami, FL, adding to the growing body of clinical and real-world evidence related to the use...